Abstract
Vitamin D (25(OH)D) levels have been associated with cardiovascular disease. Thus, the aim of our study was to investigate the association of 25(OH)D levels with coronary heart disease (CHD) in 698 consecutive type 2 diabetic outpatients. 698 consecutive type 2 diabetic outpatients (25.2 % men, age 66 ± 9 years) and 100 (90 % men, age 65 ± 13 years) age-matched non-diabetic volunteers were enrolled. 25(OH)D assay and the main cardiovascular risk factors were explored. 25(OH)D concentration was 22 ± 10 ng/ml in control subjects and 18.23 ± 10 ng/ml in diabetic patients (p < 0.01). The prevalence of hypovitaminosis D was higher in diabetic patients than in control subjects (90 vs. 83 %, p < 0.01). Diabetic subjects with hypovitaminosis D had higher prevalence of high values of A1C (p < 0.01), BMI (p < 0.01), LDL cholesterol (p < 0.01), triglycerides (p < 0.01), and glycemia (p < 0.01) than their vitamin D-sufficient counterparts. 25(OH)D and HDL cholesterol were lower (p < 0.01), while BMI (p < 0.01), age (p < 0.01), systolic (p < 0.01) and diastolic blood pressure (p < 0.01), diabetes duration (p < 0.01), A1C (p < 0.01), glycemia (p < 0.01), fibrinogen (p < 0.01), triglycerides (p < 0.01), and total (p < 0.01) and LDL cholesterol (p < 0.01) were higher in diabetic subjects with CHD than diabetic subjects without CHD. At the logistic regression analysis, the association of vitamin D with CHD was lost, while sex (p = 0.026), diabetes duration (p = 0.023), and age (p = 0.024) were the most powerful predictors of CHD. The current study demonstrates that 25(OH)D does not have a direct effect on CHD but may have an indirect effect mediated by cardiovascular risk factors such as diabetes duration, age, and sex.
Similar content being viewed by others
References
I. Bhan, Vitamin D binding protein and bone health. Int. J. Endocrinol. (2014). doi:10.1155/2014/561214
R. Scragg, M. Sowers, C. Bell, Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens. 20(7), 713–719 (2007)
S. Pilz, H. Dobnig, J.E. Fischer, B. Wellnitz, U. Seelhorst, B.O. Boehm, W. März, Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 39(9), 2611–2613 (2008)
G. Muscogiuri, G.P. Sorice, R. Ajjan, T. Mezza, S. Pilz, A. Prioletta, R. Scragg, S.L. Volpe, M.D. Witham, A. Giaccari, Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr. Metab. Cardiovasc. Dis. 22(2), 81–87 (2012)
T. Mezza, G. Muscogiuri, G.P. Sorice, A. Prioletta, E. Salomone, A. Pontecorvi, A. Giaccari, Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann. Nutr. Metab. 61(4), 337–348 (2012)
G. Muscogiuri, J. Mitri, C. Mathieu, K. Badenhoop, G. Tamer, F. Orio, T. Mezza, R. Vieth, A. Colao, A. Pittas, Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur. J. Endocrinol. 171(3), R101–R110 (2014)
T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, E.J. Benjamin, R.B. D’Agostino, M. Wolf, R.S. Vasan, Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4), 503–511 (2008)
J. Kendrick, G. Targher, G. Smits, M. Chonchol, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 205(1), 255–260 (2009)
W. Messenger, C.M. Nielson, H. Li, T. Beer, E. Barrett-Connor, K. Stone, J. Shannon, Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr. Metab. Cardiovasc. Dis. 22(10), 856–863 (2012)
J.P. Forman, J.B. Scott, K. Ng, B.F. Drake, E.G. Suarez, D.L. Hayden, G.G. Bennett, P.D. Chandler, B.W. Hollis, K.M. Emmons, E.L. Giovannucci, C.S. Fuchs, A.T. Chan, Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 61(4), 779–785 (2013)
M.M. Donneyong, C.A. Hornung, K.C. Taylor, R.N. Baumgartner, J.A. Myers, C.B. Eaton, E.Z. Gorodeski, L. Klein, L.W. Martin, J.M. Shikany, Y. Song, W. Li, J.E. Manson, Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women’s health initiative. Circ. Heart Fail. (2014). doi:10.1161/CIRCHEARTFAILURE.114.001738
L. Wang, J.E. Manson, Y. Song, H.D. Sesso, Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152(5), 315–323 (2010)
M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, J.P. Almandoz, H. Liu, M.A. Lane, R.J. Mullan, A. Hazem, P.J. Erwin, D.D. Hensrud, M.H. Murad, V.M. Montori, Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96(7), 1931–1942 (2011)
L.G. Danescu, S. Levy, J. Levy, Vitamin D and diabetes mellitus. Endocrine 35(1), 11–17 (2009)
J. Mitri, A.G. Pittas, Vitamin D and diabetes. Endocrinol. Metab. Clin. North Am. 43(1), 205–232 (2014)
Y. Song, L. Wang, A.G. Pittas, L.C. Del Gobbo, C. Zhang, J.E. Manson, F.B. Hu, Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36(5), 1422–1428 (2013)
L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, E. Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5(6), 819–829 (2012)
J.L. Anderson, H.T. May, B.D. Horne, T.L. Bair, N.L. Hall, J.F. Carlquist, D.L. Lappé, J.B. Muhlestein, Intermountain Heart Collaborative (IHC) Study Group, Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106(7), 963–968 (2010)
M. Cigolini, M.P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, G. Targher, Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29(3), 722–724 (2006)
G. Targher, L. Bertolini, R. Padovani, L. Zenari, L. Scala, M. Cigolini, G. Arcaro, Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. (Oxf.) 65(5), 593–597 (2006)
J.I. Lee, S.J. Oh, W.C. Ha, H.S. Kwon, T.S. Sohn, H.S. Son, B.Y. Cha, Serum 25-hydroxyvitamin D concentration and arterial stiffness among type 2 diabetes. Diabetes Res. Clin. Pract. 95(1), 42–47 (2012)
C. Joergensen, H. Reinhard, A. Schmedes, P.R. Hansen, N. Wiinberg, C.L. Petersen, K. Winther, H.H. Parving, P.K. Jacobsen, P. Rossing, Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care 35(1), 168–172 (2012)
S. Bonakdaran, A.R. Varasteh, Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med. J. 30(4), 509–514 (2009)
M. Chonchol, M. Cigolini, G. Targher, Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol. Dial. Transplant. 23(1), 269–274 (2008)
C. García-Cantón, E. Bosch, I. Auyanet, A. Ramírez, P. Rossique, C. Culebras, A. Sánchez, A. Toledo, M. Lago, N. Esparza, M.D. Checa, 25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease. Nefrologia 30(4), 435–442 (2010)
G. Targher, I. Pichiri, G. Lippi, Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin. Thromb. Hemost. 38(1), 114–124 (2012)
S.S. Sherman, B.W. Hollis, J.D. Tobin, Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J. Clin. Endocrinol. Metab. 71(2), 405–413 (1990)
V. Carnevale, R. Minonne, A. De Matthaeis, M.A. Annese, P. Tabacco, P. D’Arcangelo, G. D’Amico, A. Scillitani, Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department. Endocrine (2014). doi:10.1007/s12020-014-0191-4
G. Muscogiuri, G.P. Sorice, A. Prioletta, C. Policola, S. Della Casa, A. Pontecorvi, A. Giaccari, 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18(10), 1906–1910 (2010)
G. Muscogiuri, C. Policola, A. Prioletta, G. Sorice, T. Mezza, A. Lassandro, S. Della Casa, A. Pontecorvi, A. Giaccari, Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin. Nutr. 31(4), 476–480 (2012)
L.J. Maple-Brown, J.T. Hughes, Z.X. Lu, K. Jeyaraman, P. Lawton, G.R. Jones, A. Ellis, A. Sinha, A. Cass, R.J. MacIsaac, G. Jerums, K. O’Dea, Serum vitamin D levels, diabetes and cardio-metabolic risk factors in Aboriginal and Torres Strait Islander Australians. Diabetol. Metab. Syndr. 6, 78 (2014)
O.H. Ryu, W. Chung, S. Lee, K.S. Hong, M.G. Choi, H.J. Yoo, The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J. Intern. Med. 29(5), 620–629 (2014)
F.L. Vélayoudom-Céphise, L. Larifla, J.P. Donnet, S. Maimaitiming, J. Deloumeaux, A. Blanchet, C. Massart, N. Munoz-Bellili, S. Merle, R. Chout, F. Bonnet, L. Foucan, Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab. 37(6), 540–545 (2011)
Disclosure
This study has not received any specific support. None of the Authors have any conflict of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muscogiuri, G., Nuzzo, V., Gatti, A. et al. Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?. Endocrine 51, 268–273 (2016). https://doi.org/10.1007/s12020-015-0609-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0609-7